CompletedNot Applicable

Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Germany100 participantsStarted 2023-01-24

Plain-language summary

Intensive care unit acquired weakness (ICUAW) is a common issue in critically ill patients. Early mobilization can reduce the occurrence of ICUAW. This requires a standardized procedure based on validated scales. One such scale is Carol Hodgson's ICU Mobility Scale (IMS). The subject of the study is the translation of the IMS into German and the validation of its reliability and predictive power with regard to various clinical outcomes. Furthermore we want to investigate the communication about the mobilisation status of ICU-patients between the different medical disciplines that are involved in patient care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Critically ill adults (age: ≥ 18 years) * Expected length of stay in ICU \> 24h * Ventilation support Exclusion Criteria: * Patients transferred from other ICUs * Patients with pre-existing functional limitations * Patients with functional limitations due to the admission diagnosis (e.g. stroke. with hemiparesis)

What they're measuring

Predictive validity of the IMS

Timeframe: approximate 28 days (till ICU discharge)

Trial details

NCT IDNCT05591950

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-11

View on ClinicalTrials.gov More Muscle Weakness trials